# Dendrite Precision

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dendrite-precision

- Industry: Medical Devices & Equipment
- Headquarters: Hefei, China
- Website: www.dendriteprecision.com
- Latest round: Series B (Jun 25, 2024)
- Investors on record: 4

## About

Dendrite Precision develops advanced surgical imaging solutions, enhancing surgical precision with innovative technologies for improved patient outcomes.Founded in 2018, Dendrite Precision operates in Hefei, China, specializing in surgical imaging technologies. The company has successfully closed 5 deals, with its most recent funding round occurring on January 10, 2025. The founder's history includes a background in medical technology innovation, although specific prior ventures are not detailed.Anhui Dendrite Optical Technology Co., Ltd. specializes in advanced surgical imaging solutions, with its flagship product being the EndoSCell® handheld intraoperative microscope. This device enhances surgical precision by providing real-time, high-definition imaging at a micro-level, allowing surgeons to visualize cellular structures during procedures. The EndoSCell® employs unique fluorescence-guided technology to improve surgical outcomes for conditions like brain tumors, thyroid cancer, and breast cancer. The company serves a diverse client base, including hospitals such as Beijing Tiantan Hospital and Fudan University Huashan Hospital, with a market presence across major healthcare facilities in China and potential expansion to other regions.Anhui Dendrite Optical Technology Co., Ltd. generates revenue primarily through direct sales of its proprietary medical devices to hospitals and surgical centers. The transactions follow a B2B model, where healthcare providers purchase equipment tailored to specific surgical needs. The EndoSCell® is offered to medical institutions under standard purchase agreements and may include supplementary service contracts for maintenance and support. The pricing model reflects the high-value proposition of advanced surgical technology, underscoring the significant investments in research and development and production.Dendrite Precision's strategy for future growth includes the design and launch of new surgical imaging products, although specific release dates have not been disclosed. The company plans to expand its market presence beyond China into other regions, targeting key healthcare markets by 2026. The recent venture funding raised in January 2025 will be utilized to support these initiatives and enhance product development.

## Funding rounds

- Series B, Jun 25, 2024 — Hefei High-tech Venture Capital, Xingtai Capital, Guoyuan Fund
- Series A, Jun 1, 2021 — Shanghai Zhiyi Chengxi Asset Management

## Investors

- Shanghai Zhiyi Chengxi Asset Management — Series A
- Hefei High-tech Venture Capital (https://capitalatlas.ai/funds/hefei-high-tech-venture-capital) — Series B
- Xingtai Capital (https://capitalatlas.ai/funds/xingtai-capital) — Series B
- Guoyuan Fund (https://capitalatlas.ai/funds/guoyuan-fund) — Series B